Advertisement

HHS Secretary Becerra Names Lawrence Tabak, DDS, PhD, Acting Director of NIH


Advertisement
Get Permission

Lawrence A. Tabak, DDS, PhD

Lawrence A. Tabak, DDS, PhD

Health and Human Services Secretary Xavier Becerra recently announced that Lawrence A. Tabak, DDS, PhD, Principal Deputy Director of the National Institutes of Health (NIH), will serve as Acting Director of the NIH effective December 20, 2021.  

Earlier this year, current NIH Director Francis S. Collins, MD, PhD, announced his decision to end his tenure as NIH Director by the end of the year, and his last day as Director will be December 19, 2021. Dr. Collins is the longest-serving, presidentially appointed NIH Director, having served three U.S. presidents over more than 12 years.

“Dr. Tabak’s long tenure and broad experience at the NIH will ensure that the agency is in capable hands and will serve it well during the search for Dr. Collins’ successor,” Secretary Becerra said. “Dr. Tabak has a deep grasp of the most pressing scientific issues confronting our nation, he has earned respect across NIH as a thoughtful and strategic manager and is committed to building a healthier and more equitable America.”

Dr. Tabak has served as the Principal Deputy Director and the Deputy Ethics Counselor of NIH since August 2010. He previously served as the Acting Principal Deputy Director of NIH in 2009, and prior to that as Director of the National Institute of Dental and Craniofacial Research from 2000 to 2010.

Earlier Career

Prior to joining NIH, Dr. Tabak was Senior Associate Dean for Research and Professor of Dentistry and Biochemistry & Biophysics in the School of Medicine and Dentistry at the University of Rochester in New York. A former NIH MERIT recipient, Dr. Tabak's major research focus has been on the structure, biosynthesis, and function of glycoproteins. He continues work in this area, maintaining an active research laboratory within the NIH intramural program in addition to his administrative duties. 

Dr. Tabak is an elected member the National Academy of Medicine (formerly Institute of Medicine) of the National Academies. He received his undergraduate degree from City College of New York, his DDS from Columbia University, and a PhD from the University of Buffalo.

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
Advertisement

Advertisement




Advertisement